June 29, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHILADELPHIA — Medications that reduce blood pressure and improve glycemia may preserve kidney function over time despite initial eGFR dips, according to a speaker at the Heart in Diabetes CME Conference. Matthew R. Weir, MD, professor and chief in the division of nephrology at University of Maryland School of Medicine, said eGFR dips “should be expected and planned upon” when using
June 29, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

PHILADELPHIA — Using a GLP-1 receptor agonist in combination with an SGLT2 inhibitor may provide additive cardiovascular and…

CHICAGO — In patients being treated for hypertension, those taking a GLP-1 receptor agonist had higher rates of hypotensive…

An update to the previously published multispeciality guide for the management of diabetes, cardiorenal and metabolic diseases…

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and Sean M.…

PHILADELPHIA — Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that…

U.S. pharmacy organizations are advocating for the use of the 2021 race-neutral CKD-EPI equation for “medication-related…